Question 1

What is Bio-Techne's P/B ratio?

Accepted Answer

Bio-Techne (TECH) P/B ratio is 3.9× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by book value of equity, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/B ratio calculated?

Accepted Answer

P/B = Market Capitalisation ÷ Book Value of Equity (most recent quarterly shareholders' equity), or equivalently Share Price ÷ Book Value Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/B ratio?

Accepted Answer

The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.

Question 4

What is a good P/B ratio for Bio-Techne?

Accepted Answer

A "good" P/B depends on the business model. Banks, insurers, and other capital-heavy financials typically trade near 1×; asset-light technology and consumer-brand companies can sustainably trade at 5×+ because much of their value is intangible. P/B is most informative when paired with return on equity (ROE). For Bio-Techne specifically, the relevant sector benchmark is the current sector median of 3.4×.

Question 5

Is Bio-Techne's P/B ratio high or low?

Accepted Answer

Bio-Techne's P/B ratio of 3.9× is below its own 5-year average of 6.7× and above the sector median of 3.4×. That places the current reading at the 4th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Bio-Techne's historical P/B ratio range?

Accepted Answer

In the available daily series, Bio-Techne (TECH) P/B ratio has ranged from a low of 3.3× in 2026 to a high of 14.1× in 2021. The 5-year average is 6.7× and the 5-year median is 6.1×.

Question 7

What was Bio-Techne's P/B ratio in 2025?

Accepted Answer

Bio-Techne (TECH) P/B ratio at the end of 2025 was 4.2×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month book value figure available at that date.

Question 8

Why does Bio-Techne's P/B ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (book value). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$7.97B	$1.92B	4.2×	-1.3×	Jun 30, 2025
2024	$11.30B	$2.07B	5.5×	-1.1×	Jun 30, 2024
2023	$12.86B	$1.97B	6.5×	-1.4×	Jun 30, 2023
2022	$13.59B	$1.70B	8.0×	-3.2×	Jun 30, 2022
2021	$17.52B	$1.56B	11.2×	+3.9×	Jun 30, 2021
2020	$10.12B	$1.38B	7.3×	+0.5×	Jun 30, 2020
2019	$7.93B	$1.17B	6.8×	+1.6×	Jun 30, 2019
2018	$5.56B	$1.08B	5.2×	+0.5×	Jun 30, 2018
2017	$4.39B	$950.83M	4.6×	-0.2×	Jun 30, 2017
2016	$4.20B	$879.28M	4.8×	+0.5×	Jun 30, 2016
2015	$3.66B	$846.93M	4.3×	+0.0×	Jun 30, 2015
2014	$3.42B	$795.26M	4.3×	+0.8×	Jun 30, 2014
2013	$2.57B	$737.54M	3.5×	-0.6×	Jun 30, 2013
2012	$2.73B	$674.44M	4.1×	-1.2×	Jun 30, 2012
2011	$3.09B	$586.12M	5.3×	+1.0×	Jun 30, 2011
2010	$2.13B	$501.79M	4.2×	-1.0×	Jun 30, 2010
2009	$2.38B	$456.48M	5.2×	-0.9×	Jun 30, 2009
2008	$2.99B	$487.13M	6.1×	+1.0×	Jun 30, 2008
2007	$2.26B	$437.65M	5.2×	-0.7×	Jun 30, 2007
2006	$2.01B	$340.35M	5.9×	-0.8×	Jun 30, 2006
2005	$1.78B	$267.87M	6.6×	+0.6×	Jun 30, 2005
2004	$1.79B	$297.43M	6.0×	+0.8×	Jun 30, 2004
2003	$1.24B	$236.62M	5.3×	-0.3×	Jun 30, 2003
2002	$1.15B	$206.52M	5.6×	—	Jun 30, 2002


Quest Diagnostics (DGX)	2.9×
Moderna (MRNA)	2.7×
Charles River (CRL)	2.6×
Regeneron Pharmaceuticals (REGN)	2.6×
Henry Schein (HSIC)	2.5×
Labcorp Holdings (LH)	2.5×
Danaher (DHR)	2.4×
UnitedHealth Group (UNH)	2.4×
Solventum (SOLV)	2.3×
Becton, Dickinson and (BDX)	1.8×
Pfizer (PFE)	1.8×
Molina Healthcare (MOH)	1.7×
Cigna (CI)	1.7×
Waters Corporation (WAT)	1.6×
Cooper Companies (COO)	1.5×
Elevance Health (ELV)	1.5×
Universal Health Services (UHS)	1.5×
Biogen (BIIB)	1.4×
Baxter International (BAX)	1.4×
Revvity (RVTY)	1.4×
Zimmer Biomet Holdings (ZBH)	1.2×
CVS Health (CVS)	1.2×
Humana (HUM)	1.1×
Viatris (VTRS)	1.1×
Centene (CNC)	0.8×

P/B Ratio for Bio-Techne (TECH)

P/B Ratio daily chart for Bio-Techne (TECH)

Historical P/B Ratio for Bio-Techne (TECH) from 2002 to 2025

About P/B Ratio at Bio-Techne (TECH)

Bio-Techne P/B Ratio by Year

Bio-Techne P/B Ratio 2025: 4.2×

Bio-Techne P/B Ratio 2024: 5.5×

Bio-Techne P/B Ratio 2023: 6.5×

Bio-Techne P/B Ratio 2022: 8.0×

Bio-Techne P/B Ratio 2021: 11.2×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

Bio-Techne (TECH) Key Financials

P/B Ratio daily chart for Bio-Techne (TECH)

Historical P/B Ratio for Bio-Techne (TECH) from 2002 to 2025

About P/B Ratio at Bio-Techne (TECH)

Bio-Techne P/B Ratio by Year

Bio-Techne P/B Ratio 2025: 4.2×

Bio-Techne P/B Ratio 2024: 5.5×

Bio-Techne P/B Ratio 2023: 6.5×

Bio-Techne P/B Ratio 2022: 8.0×

Bio-Techne P/B Ratio 2021: 11.2×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

+What is Bio-Techne's P/B ratio?

+How is the P/B ratio calculated?

+What is the P/B ratio?

+What is a good P/B ratio for Bio-Techne?

+Is Bio-Techne's P/B ratio high or low?

+What is Bio-Techne's historical P/B ratio range?

+What was Bio-Techne's P/B ratio in 2025?

+Why does Bio-Techne's P/B ratio change over time?

Bio-Techne (TECH) Key Financials